Details for New Drug Application (NDA): 062687
✉ Email this page to a colleague
NDA 062687 describes ERYTHRA-DERM, which is a drug marketed by Micro Labs and is included in one NDA. It is available from one supplier. Additional details are available on the ERYTHRA-DERM profile page.
The generic ingredient in ERYTHRA-DERM is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
The generic ingredient in ERYTHRA-DERM is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 062687
| Tradename: | ERYTHRA-DERM |
| Applicant: | Micro Labs |
| Ingredient: | erythromycin |
| Patents: | 0 |
Pharmacology for NDA: 062687
| Physiological Effect | Decreased Sebaceous Gland Activity |
Medical Subject Heading (MeSH) Categories for 062687
Suppliers and Packaging for NDA: 062687
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ERYTHRA-DERM | erythromycin | SOLUTION;TOPICAL | 062687 | ANDA | Saptalis Pharmaceuticals, LLC LLC | 71656-030 | 71656-030-60 | 1 BOTTLE in 1 CARTON (71656-030-60) / 60 mL in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | 2% | ||||
| Approval Date: | Feb 5, 1988 | TE: | AT | RLD: | No | ||||
Complete Access Available with Subscription
